Concepedia

Kirk W. Johnson

KW

Statistics

Publications

2

Citations

187

H-Index

2

Active since

1997

Affiliations

Eli Lilly (United States)(Current)

Kirk W. Johnson is an author at Eli Lilly (United States) specializing in neuroimmunology, neuropharmacology, and medicine.

Top concepts

MedicinePharmacologyNeuroimmunologyNeuropharmacologyNeurologyImmunologyInflammationNeuroscienceNeurochemistryNeurophysiology

Publications per year

1997–1997

2

Publications

2

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

Lee A. Phebus, Kirk W. Johnson, John M. Zgombick et al. · Life Sciences · 1997 · 139 citations · Full text

Neurophysiology, Medicine, Pharmacology +13

The non-pfjptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs

Lee A. Phebus, Kirk W. Johnson, Peter W. Stengel et al. · Life Sciences · 1997 · 48 citations

Inflammation, Molecular Pharmacology, Guinea Pigs +10

1–2 of 2